News

The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. UK SMA Research Online Conference – 10th & 11 September 2020

    Save the date for the UK SMA Research Online Conference, which will take place on 10th & 11th September between 1 and 4.30pm GMT. A committee of UK-based PhD students have got together to organise this event with the aim of giving early career researchers (ECRs) an opportunity to present their work. There will be […]

    READ MORE

  2. SMA Europe held its bi-annual meeting in Berlin

    SMA Europe held its bi-annual meeting in Berlin on 13th and 14th October 17, kindly hosted by Initiative SMA, an initiative of the German neuromuscular organisation, Deutsche Gesellschaft für Muskelkranke (DGM). A number of topics were discussed, from the availability and scope of Spinraza™ reimbursement across different European countries, to SMA Europe’s International Scientific Congress for […]

    READ MORE

  3. SMA Europe bi-annual meeting – October 2017

    SMA Europe is hodling its second annual meeting of the year, kindly hosted by the German neuromuscular disease association, DGM (Deutsche Gesellschaft  für Muskelkranke e.V.) in Berlin between 13th & 14th October 2017. The programme will include: Individual meetings with the main pharmaceutical companies involved in the development of therapies for SMA (Avexis, Biogen, Novartis […]

    READ MORE

  4. SMA Europe organises first European SMA Research Conference!

    SMA Europe organises the first SMA Research Conference, which will take place in Krakow, Poland, between 25th & 27th January 2018. We have an exciting programme and talks by most of the world experts in SMA: Key note: Where have we come, where do we go? Arthur Burghes Session 1: SMN function importance in the […]

    READ MORE

  5. SMA Europe Annual Meetings 2017

    SMA Europe’s annual meetings this year were hosted by the Dutch neuromuscular disease association, VSN (Vereniging Spierziekten Nederland) in Utrecht between 6th & 8th April 2017. The programme included: joint and individual meetings with the main pharmaceutical companies involved in the development of therapies for SMA; the review of 21 SMA research grant applications by […]

    READ MORE